BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In Ph+ cells of CML patients, these properties are not studied due to lack of suitable models and experimental approaches, though the bcr/abl mutations are actively studied and used in practice for CML diagnosis and treatment optimization [19, 29, 30-32].